Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SPXV vs SPXT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SPXT Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

SPXT Overall Winner 6-Pillar Tally: SPXV 0 – 0 SPXT (6 Tie) Matrix Metrics: SPXV 1 – 2 SPXT

As of Nov 16, 2026, ProShares S&P 500 Ex-Technology ETF (SPXT) is the stronger overall head-to-head candidate over ProShares S&P 500 Ex-Health Care ETF (SPXV) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). SPXV carries a Unified Composite Score of 58.7/100 (HOLD) at $79.74 (N/M Forward P/E, N/A operating margin), whereas SPXT carries 48.8/100 (HOLD) at $112.08 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While SPXV currently prints a higher short-term Unified Composite Score (58.7/100 HOLD vs. SPXT 48.8/100 HOLD), SPXT captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Technical & Structure Timing Caution: SPXV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.0); meanwhile SPXT trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SPXV vs SPXT
SPXV NYSE Arca
ProShares S&P 500 Ex-Health Care ETF
Institutional Equity
$79.74
-2.1% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.06β · 23% Vol
Unified Composite Score
58.7 / 100 HOLD
Tech 74.0 Fund 53.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.9%) with fading momentum, RSI 45
RSI-14: 45.0 · SMA20: $82.29 · SMA50: $83.40
SPXT NYSE Arca Head-to-Head Winner
ProShares S&P 500 Ex-Technology ETF
Institutional Equity
$112.08
-1.29% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.59β · 16% Vol
Unified Composite Score
48.8 / 100 HOLD
Tech 54.0 Fund 46.0 Flow 50.0 Mom 31.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 52.8 · SMA20: $111.62 · SMA50: $110.24

6-Pillar Scorecard Institutional Category Breakdown (SPXV 0 – 0 SPXT)

Columns: Metric · SPXV · SPXT
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 221.1% (92nd %ile) 13.4% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SPXV (1) vs SPXT (2)
Institutional Metric SPXV SPXT Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
65% ($69–$86) 84% ($99–$115) Stronger Trend SPXT
Beta / 30D Volatility
Risk Regime
1.06β · 23% Vol 0.59β · 16% Vol Lower Realized Risk SPXT
Unified Institutional Score
Composite Signal
58.7 / 100 (HOLD) 48.8 / 100 (HOLD) Higher Composite SPXV
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SPXT +5.26 pp
SPXV: -4.15% · SPXT: +1.11%
3M Horizon SPXT +5.2 pp
SPXV: -5.07% · SPXT: +0.13%
6M Horizon SPXT +6.15 pp
SPXV: -2.39% · SPXT: +3.76%
1Y Horizon SPXT +1.95 pp
SPXV: +8.85% · SPXT: +10.8%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SPXV vs SPXT. Trailing 12-month operating profitability (SPXV N/A vs SPXT N/A) and valuation multiples (SPXV N/M vs SPXT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SPXV ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SPXT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SPXV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 221.1%
IV Percentile 92nd %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SPXV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SPXT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 13.4%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SPXT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SPXV Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SPXT Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SPXV vs SPXT Key Questions & Quantitative Answers

As of Nov 16, 2026, ProShares S&P 500 Ex-Technology ETF (SPXT) is the stronger overall head-to-head candidate over ProShares S&P 500 Ex-Health Care ETF (SPXV) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). SPXV carries a Unified Composite Score of 58.7/100 (HOLD) at $79.74 (N/M Forward P/E, N/A operating margin), whereas SPXT carries 48.8/100 (HOLD) at $112.08 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While SPXV currently prints a higher short-term Unified Composite Score (58.7/100 HOLD vs. SPXT 48.8/100 HOLD), SPXT captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: SPXV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.0); meanwhile SPXT trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SPXV and SPXT split Growth & Scale metrics: SPXV posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SPXT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SPXV generates N/A in USD-normalized revenue versus N/A for SPXT. In operating R&D and SG&A reinvestment, SPXV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SPXT.

SPXV and SPXT trade at balanced relative valuation multiples. SPXV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SPXT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SPXV (N/A ROE) versus SPXT (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, SPXV carries 221.1% implied volatility (92nd %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.06β · 23% Vol realized risk). By comparison, SPXT carries 13.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.59β · 16% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.